Loading...

Merck & Co., Inc.

MRKNYSE
HealthcareDrug Manufacturers - General
$77.66
$-0.61(-0.78%)

Merck & Co., Inc. MRK Peers

See (MRK) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
MRK$77.66-0.78%195B11.29$6.88+4.07%
LLY$765.91+0.01%725.9B62.22$12.31+0.73%
AZN$72.35-0.89%448.6B29.17$2.48+2.13%
JNJ$153.67+0.29%369.7B17.09$8.99+3.26%
ABBV$187.40+0.03%331B80.09$2.34+3.39%
NVO$72.59+0.76%325.6B20.33$3.57+2.22%
NVS$117.80+0.74%232.7B18.46$6.38+3.39%
AMGN$287.10+0.03%154.4B26.17$10.97+3.20%
GILD$110.45+1.31%137.4B14.27$7.74+2.80%
PFE$23.11-1.20%131.4B16.75$1.38+7.35%
Showing 1 to 10 of 24 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MRK vs LLY Comparison

MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MRK stands at 195B. In comparison, LLY has a market cap of 725.9B. Regarding current trading prices, MRK is priced at $77.66, while LLY trades at $765.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MRK currently has a P/E ratio of 11.29, whereas LLY's P/E ratio is 62.22. In terms of profitability, MRK's ROE is +0.38%, compared to LLY's ROE of +0.77%. Regarding short-term risk, MRK is less volatile compared to LLY. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.

Stock Price Comparison

Loading...

Frequently Asked Questions